Education
About Us
Working with TipRanks
Follow Us
Therma Bright (TSE:THRM)
:THRM
THRM Stock Chart & Stats
C$0.06
>-C$0.01(-12.50%)
At close: 4:00 PM EST
C$0.06
>-C$0.01(-12.50%)
Day’s Range― - ―
52-Week RangeC$0.05 - C$0.28
Previous CloseN/A
Volume10.00K
Average Volume (3M)50.06K
Market Cap
C$3.19M
Enterprise ValueC$3.50M
Total Cash (Recent Filing)C$65.59K
Total Debt (Recent Filing)C$40.00K
Price to Earnings (P/E)―
Beta0.26
Next Earnings
Apr 07, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding58,002,876
10 Day Avg. Volume51,225
30 Day Avg. Volume50,057
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)-2.51
Price to Sales (P/S)48.92
P/FCF Ratio-26.80
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Focused Healthcare Product PortfolioA focused product set—non-contact temperature screening and diagnostic test devices—aligns with durable healthcare needs (infection screening, point-of-care testing). Institutional buyers and healthcare channels create structural demand, aiding steady adoption and long-term commercial relevance.
Recurring Consumables OpportunityThe business model includes consumable diagnostic reorders, a durable source of recurring revenue if an installed base grows. Recurring skus can raise revenue visibility, improve lifetime customer value, and support margin sustainability as device install-base expands over months to years.
Low Reported DebtVery low reported debt materially reduces interest and covenants pressure, giving management flexibility to pursue commercial traction or raise capital on less strained terms. Lower leverage improves short-term solvency and preserves optionality during scaling.
Bears Say
Tiny And Declining Revenue BaseA ~$75k TTM revenue base that is shrinking undermines economies of scale, limits ability to cover fixed R&D and SG&A, and weakens bargaining leverage with distributors. Without meaningful top-line growth, sustained commercialization and margin improvement are difficult.
Deep Unprofitability And Negative EquitySustained net losses (~-55% margin) have produced negative shareholders' equity, signaling accumulated deficits. This erodes financial cushions, constrains strategic options, and increases the likelihood of dilutive financing or restructuring to restore a viable capital structure.
Negative Operating And Free Cash FlowPersistently negative OCF and FCF mean the company cannot internally fund growth or cover losses, forcing reliance on external capital. Over time this raises financing risk, potential dilution, and can delay commercial expansions or product investments essential for durable revenue growth.
Therma Bright News
THRM FAQ
What was Therma Bright’s price range in the past 12 months?
Therma Bright lowest stock price was C$0.04 and its highest was C$0.28 in the past 12 months.
What is Therma Bright’s market cap?
Therma Bright’s market cap is C$3.19M.
When is Therma Bright’s upcoming earnings report date?
Therma Bright’s upcoming earnings report date is Apr 07, 2026 which is in 30 days.
How were Therma Bright’s earnings last quarter?
Therma Bright released its earnings results on Dec 01, 2025. The company reported -C$0.004 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.004.
Is Therma Bright overvalued?
According to Wall Street analysts Therma Bright’s price is currently Overvalued.
Does Therma Bright pay dividends?
Therma Bright does not currently pay dividends.
What is Therma Bright’s EPS estimate?
Therma Bright’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Therma Bright have?
Therma Bright has 58,002,876 shares outstanding.
What happened to Therma Bright’s price movement after its last earnings report?
Therma Bright reported an EPS of -C$0.004 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Therma Bright?
Currently, no hedge funds are holding shares in TSE:THRM
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Therma Bright
Therma Bright Inc. engages in the development and sale of rapid COVID testing products, medical devices for pain management, devices to improve circulation, and devices for the cosmeceutical industry. The company's products include AcuVid, an antigen and antibody rapid screening test for COVID-19; InterceptCS, a cold sore prevention system, which provides controlled topical heat without the risk of burning the skin; Benepod, a hot and cold contrast therapy device for pain relief without pain relieving medication; Venowave, a medical compression pump designed to treat and alleviate the symptoms associated with poor circulation; and TherOZap, a thermal therapy insect device that reduces the inflammatory response, as well as relieves the symptoms of pain, itching, and inflammation associated with insect bites and stings. It serves consumers and medical professionals. The company was formerly known as The Jenex Corporation and changed its name to Therma Bright Inc. in February 2018. Therma Bright Inc. was incorporated in 2001 and is based in Toronto, Canada.
Technical Analysis
Imagin Medical
―
Perimeter Medical Imaging AI
―
Profound Medical
―
Theralase Technologies
―
Aquarius Surgical Technologies
―
Options Prices
Currently, No data available
---